928
Participants
Start Date
July 18, 2024
Primary Completion Date
December 3, 2024
Study Completion Date
December 3, 2024
FDA warnings + Image
For six days (days 2-7) participants will be contacted and asked to complete a daily survey. As part of the survey, participants will view FDA-proposed LCC warnings with images at 30% size on a cigarillo package. Participants will be contacted each day to be invited to complete the survey for that day of the study protocol.
FDA Warnings Text-Only
Participants will receive messages including images in 30% size.
Surgeon General Text-Only Warnings
Participants will receive messages including Surgeon General Text-only Warnings.
Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill
National Cancer Institute (NCI)
NIH
Food and Drug Administration (FDA)
FED
UNC Lineberger Comprehensive Cancer Center
OTHER